What is the Tonix Pharmaceuticals Holding Corp. stock price forecast?

Tonix Pharmaceuticals Holding Corp. is currently trading at $11.63. View real-time AI analysis on Alpha Lenz.

What is Tonix Pharmaceuticals Holding Corp. insider trading activity?

View the latest insider trading data for Tonix Pharmaceuticals Holding Corp. on Alpha Lenz.

What is Tonix Pharmaceuticals Holding Corp.'s P/E ratio?

Tonix Pharmaceuticals Holding Corp.'s P/E ratio is -0.8.

Tonix Pharmaceuticals Holding Corp.

NASDAQ · TNXP

$11.63+0.11(+0.91%)Pre-market

Ask about Tonix Pharmaceuticals Holding Corp.'s future dividend policy...

Alpha Chat Insight

“Tonix Pharmaceuticals Holding Corp. trades at a P/E of -0.8 (undervalued) with modest ROE of -64.5%.”

Ask for details →

Company Overview

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company focused on discovering, developing, and licensing novel therapies for a range of medical conditions. The company's primary goal is to develop innovative pharmaceutical products that address significant unmet medical needs within neurology, oncology, immunology, and infectious diseases. Tonix's research efforts are concentrated on central nervous system disorders, infectious diseases like COVID-19, and pain management, aiming to improve quality of life for patients globally. The company’s pipeline includes both small molecules and biologics, emphasizing advanced drug delivery mechanisms and novel targets. With a commitment to scientific excellence and innovation, Tonix Pharmaceuticals collaborates with academic and commercial partners to advance its research initiatives. Headquartered in New Jersey, the company plays a significant role in the pharmaceutical and biotechnology sectors by pursuing solutions for complex healthcare challenges, striving to bring groundbreaking therapies to market and contribute to medical advancements.

CEODr. Seth Lederman M.D.

Websitehttps://www.tonixpharma.com

SectorHealthcare

IndustryBiotechnology

Employees81

Company Statistics

FY 2025

Profile

$98.99MMarket Cap

$13.11MRevenue

0.00Shares Out

81Employees

Margins

49.34%Gross

-914.89%EBITDA

-936.07%Operating

-946.22%Pre-Tax

-946.22%Net

Valuation

-0.80P/E

0.40P/B

7.55EV/Sales

0.90EV/EBITDA

-0.96P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-56.37%ROA

-64.48%ROE

-56.32%ROIC

Financial Health

$207.64MCash & Cash Equivalents

$-175.62MNet Debt

13.06%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Tonix Pharmaceuticals Holding Corp. trades at a P/E of -0.8 (undervalued) with modest ROE of -64.5%.”

Ask for details →

Frequently Asked Questions

Tonix Pharmaceuticals Holding Corp. (ticker: TNXP) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 81 employees. Market cap is $99M.

The current price is $11.63 with a P/E ratio of -0.8x and P/B of 0.4x.

ROE is -64.48% and operating margin is -936.07%. Annual revenue is $13M.